Skip to content
Pharmed UGPHARMED UG
← Back to the collection
PHARMED MARSHMALLOW THROAT LOZENGES packaging visualisation
H02 · PHARMED UG

MARSHMALLOW THROAT LOZENGES

Marshmallow root extract

Marshmallow root87.5 mg per lozenge, with botanical flavours; device development profile.

Proposed pack20 lozenges
FormatLozenge

Complete selected ingredient declaration

Marshmallow root extract; liquid isomalt; citric acid; grape concentrate; menthol; blackcurrant flavour; eucalyptus oil; geranium flavour; sucralose; water; maltitol syrup; thyme extract; ribwort plantain extract; glycerol; soy lecithin. Further separately declared constituents:propylene glycol and sorbitol.

Published component amounts

ComponentAmountExact table basis
Marshmallow root extract87.5 mg1 lozenge
Isomaltitol+maltitol combined2.5 g1 lozenge
Propylene glycol2.5 mg1 lozenge
Sorbitol20 mg1 lozenge

Each row retains its source basis. Amounts per tablet, daily portion, 100 g, 100 mL and prepared serving are distinct. “Not published” means undisclosed, not zero. Raw-material input masses and processing allowances require the manufacturer specification.

Development status

This specialist format is a formulation development profile. Source medicine, medical-device or cosmetic status and approvals do not transfer to PHARMED. The responsible manufacturer must establish the final intended use, classification, directions, safety and market label.

Exact shared PHARMED H02 label front

The shared label design

This is the exact front artwork used in the catalogue and measured factory artwork. The three-dimensional packaging image illustrates its presentation.

Open the master front